Dynamic changes in accessibility, nuclear positioning, recombination, and transcription at the Ig kappa locus.
The 3-megabase Igkappa locus undergoes differentially controlled nuclear positioning events and chromatin structural changes during the course of B cell development. The temporal association of chromatin structural changes, transcription, and recombination at the Igkappa locus was determined in a murine pre-B cell line that can be induced to recombine at the Igkappa locus and in ex vivo-cultured murine pre-B cells. Additionally, the timing of nuclear positioning relative to the temporal order of chromatin structural changes and recombination and transcription was determined. We demonstrate that before induction, the Igkappa locus was poised for recombination; both alleles were in a contracted state, and the enrichment of histone modifications and germline transcripts of specific Vkappa genes were observed. Histone modifications of the Vkappa genes did not vary upon induction but the levels of modifications correlated with the levels of germline Vkappa gene transcripts and recombination. Upon induction, but before VkappaJkappa recombination, centromeric recruitment of single Igkappa alleles occurred. DNase I sensitivity of the entire locus increased gradually over the course of differentiation while the enrichment of histone modifications downstream of the Vkappa genes was increased in the silencer regions upstream of Jkappa1, within the Igkappa sterile transcript, the kappa constant region, the Ekappai and Ekappa3' enhancers, and the recombining sequence. The ex vivo pre-B cells showed similar patterns of histone modifications across the locus except at the Vkappa genes. In this study, H3 acetylation correlated with levels of germline transcripts while H3 methylation correlated with levels of recombination.
Fitzsimmons
Sean P
SP
Division of Monoclonal Antibodies, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD 20852, USA.
Bernstein
Ralph M
RM
Max
Edward E
EE
Skok
Jane A
JA
Shapiro
Marjorie A
MA
D000483:Alleles; D000818:Animals; D002454:Cell Differentiation / Q000235:genetics / Q000276:immunology; D002461:Cell Line, Transformed; D045744:Cell Line, Tumor; D002467:Cell Nucleus / Q000235:genetics* / Q000276:immunology / Q000378:metabolism*; D002478:Cells, Cultured; D002843:Chromatin / Q000235:genetics / Q000378:metabolism; D003850:Deoxyribonuclease I / Q000235:genetics / Q000378:metabolism; D015322:Gene Rearrangement, B-Lymphocyte / Q000276:immunology*; D005819:Genetic Markers; D018095:Germ-Line Mutation / Q000276:immunology; D006657:Histones / Q000235:genetics / Q000378:metabolism; D007135:Immunoglobulin Variable Region / Q000235:genetics / Q000378:metabolism; D007145:Immunoglobulin kappa-Chains / Q000235:genetics* / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D011995:Recombination, Genetic / Q000276:immunology*; D013234:Stem Cells / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D013997:Time Factors; D014158:Transcription, Genetic / Q000276:immunology*
D002843:Chromatin; D005819:Genetic Markers; D006657:Histones; D007135:Immunoglobulin Variable Region; D007145:Immunoglobulin kappa-Chains; D003850:Deoxyribonuclease I